Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights
Open accessThe DOI matches its Crossref record; 187 of the 189 references it cites were found in a registry or an index.
Abstract
Despite some significant advancements, breast cancer has become the most prevalent cancer in the world. One of the main reasons for failure in treatment and metastasis has been attributed to the presence of cancer initiating cells-cancer stem cells. Consequently, research is now being focussed on targeting cancer cells along with their stem cell population. Non-oncology drugs are gaining increasing attention for their potent anticancer activities. Metformin, a drug commonly used to treat type 2 diabetes, is the best example in this regard. It exerts its therapeutic action by activating 5' adenosine monophosphate-activated protein kinase (AMPK). Activated AMPK subsequently phosphorylates and targets several cellular pathways involved in cell growth and proliferation and the maintenance of stem-like properties of cancer stem cells. Therefore, AMPK is emerging as a target of choice for developing effective anticancer drugs. Vanadium compounds are well-known PTP inhibitors and AMPK activators. They find extensive applications in treatment of diabetes and obesity via PTP1B inhibition and AMPK-mediated inhibition of adipogenesis. However, their role in targeting cancer stem cells has not been explored yet. This review is an attempt to establish the applications of insulin mimetic vanadium compounds for the treatment of breast cancer by AMPK activation and PTP1B inhibition pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, activated AMPK phosphorylates and disarms key components of pathways involved in cell growth and maintenance of cancer cell stemness, thus constituting a potential target of anticancer drugs.228”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [228]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lee, H., Park, H. J., Park, C., Oh, E., Choi, B.-H., Williams, B. W., Lee, C. K. K., & Song, C. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087979 · Cited by 97 · cited 1×
“AMPK activation by metformin also involves downregulation of mTOR for the anticancer effect [91,92].”
BackgroundRetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 3×
“They discovered that as few as 100 of these cells were potent enough to form tumours when xenotransplanted in mice [5].”
BackgroundThe Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914 · cited 1×
“Activated AMPK suppresses mTOR by phosphorylating and activating the tuberous sclerosis complex (TSC) that negatively regulates mTOR signalling [23,89,90].”
BackgroundMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Many independent systematic studies reported lower risk and occurrences of cancer in diabetic patients on metformin treatment [21,22].”
BackgroundZhou, S., Schuetz, J. D., Bunting, K. D., Colapietro, A.-M., Sampath, J., Morris, J. J., Lagutina, I., Grosveld, G. C., Osawa, M., Nakauchi, H., et al. (2001) · Nature Medicine · doi:10.1038/nm0901-1028 · Cited by 2,280 · cited 1×
“Therefore, BCSCs are fundamentally more resistant to the currently employed clinical techniques (chemo and radiation) [5,9].”
BackgroundTargeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer
Snaebjornsson, M. T., Janaki-Raman, S., & Schulze, A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.010 · Cited by 1,097 · cited 2×
“Unlike normal cells, cancer cells are commonly characterised by enhanced activity of fatty acid and lipid synthesizing enzymes to compensate for the additional energy and nutrition requirement of fast proliferating cells [77].”
BackgroundTargeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.001 · Cited by 911
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
Corsello, S. M., Nagari, R. T., Spangler, R. D., Rossen, J., Kocak, M., Bryan, J. G., Humeidi, R., Peck, D., Wu, X., Tang, A. A., et al. (2020) · Nature Cancer · doi:10.1038/s43018-019-0018-6 · Cited by 878 · cited 2×
“Recently, there was also a study reporting a systematic screening of over 4000 FDA approved drugs for over 500 cancer cell lines using PRISM software analysis [19].”
BackgroundLiang, J., Shao, S. H., Xu, Z.-X., Hennessy, B., Ding, Z., Larrea, M., Kondo, S., Dumont, D. J., Gutterman, J. U., Walker, C. L., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1537 · Cited by 866 · cited 2×
“Cyclovirobuxine D MCF7 AMPK autophagy [64]”
BackgroundAMPK activators: mechanisms of action and physiological activities
Kim, J., Yang, G., Kim, Y., Kim, J., & Ha, J. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.16 · Cited by 817 · cited 1×
“The generally accepted mechanism for physiological AMPK activation involves phosphorylation of the Thr-172 residue within the catalytic active site of AMPKα subunit mainly by LKB1 (liver kinase B1) and CaMKKβ (Ca2+/calmodulin-dependent protein kinase β) [35,36].”
BackgroundMetformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1
Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J.-F., Giorgetti-Peraldi, S., & Bost, F. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1769 · Cited by 616 · cited 1×
“However, there are a few reports suggesting the metformin-mediated repression of mTOR can be independent of AMPK as well [26].”
BackgroundVanadium compounds in medicine
Pessoa, J. C., Etcheverry, S., & Gambino, D. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.12.002 · Cited by 561
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
Korkaya, H., Paulson, A., Iovino, F., & Wicha, M. S. (2008) · Oncogene · doi:10.1038/onc.2008.207 · Cited by 556 · cited 1×
“This treatment approach is also proposed to act against the ALDH1 cancer stem cell population [14,15].”
BackgroundAntidiabetic vanadium(IV) and zinc(II) complexes
Sakurai, H., Kojima, Y., Yoshikawa, Y., Kawabe, K., & Yasui, H. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(01)00447-7 · Cited by 537
Vanadium treatment of type 2 diabetes: A view to the future
Thompson, K. H., Lichter, J., LeBel, C., Scaife, M. C., McNeill, J. H., & Orvig, C. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.12.003 · Cited by 520
Vanadium in diabetes: 100 years from Phase 0 to Phase I
Thompson, K. H., & Orvig, C. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.08.016 · Cited by 508
Liu, H., Patel, M. R., Prescher, J. A., Patsialou, A., Qian, D., Lin, J., Wen, S., Chang, Y.-F., Bachmann, M. H., Shimono, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006732107 · Cited by 465 · cited 1×
“Breast cancer stem cells display increased cell motility and invasion and they overexpress genes that promote metastasis [8].”
BackgroundGandini, S., Puntoni, M., Heckman-Stoddard, B. M., Dunn, B. K., Ford, L., DeCensi, A., & Szabo, E. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0424 · Cited by 457 · cited 2×
“Metformin treatment significantly reduces the sphere-forming ability and inhibits proliferation in the CD44+CD24− and ALDH+ stem-cell-rich population in breast cancer cells [21,24].”
BackgroundPI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application.
Pu, X., & Xu, X. (2015) · Europe PMC (PubMed Central) · Cited by 453
Understanding the benefit of metformin use in cancer treatment
Dowling, R. J., Goodwin, P. J., & Stambolic, V. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-33 · Cited by 409 · cited 1×
“Activated AMPK suppresses mTOR by phosphorylating and activating the tuberous sclerosis complex (TSC) that negatively regulates mTOR signalling [23,89,90].”
BackgroundHowell, J. J., Hellberg, K., Turner, M., Talbott, G., Kolar, M. J., Ross, D. S., Hoxhaj, G., Saghatelian, A., Shaw, R. J., & Manning, B. D. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.009 · Cited by 408 · cited 2×
“mTORC1 is a nutrition-sensitive protein complex composed of mTOR kinase and the scaffolding protein raptor, catalysing various biosynthetic pathways in the human body [83].”
BackgroundMetformin: Taking away the candy for cancer?
Jalving, M., Gietema, J. A., Lefrandt, J. D., Jong, S. D., Reyners, A. K. L., Gans, R. O. B., & Vries, E. G. E. D. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.06.012 · Cited by 380 · cited 2×
“AMPK is identified as the crucial candidate causing the interaction between metabolism and cancer [28,29].”
BackgroundTargeting the disordered C terminus of PTP1B with an allosteric inhibitor
Krishnan, N., Koveal, D., Miller, D. H., Xue, B., Akshinthala, S. D., Kragelj, J., Jensen, M. R., Gauss, C.-M., Page, R., Blackledge, M., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1528 · Cited by 372
Targeting Breast Cancer Stem Cells
Liu, S., & Wicha, M. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5388 · Cited by 356
Treviño, S., Díaz, A., Sánchez-Lara, E., Sanchez-Gaytan, B. L., Perez-Aguilar, J. M., & González-Vergara, E. (2019) · Biological Trace Element Research · doi:10.1007/s12011-018-1540-6 · Cited by 354
Saraei, P., Asadi, I., Kakar, M. A., & Moradi-Kor, N. (2019) · Cancer Management and Research · doi:10.2147/cmar.s200059 · Cited by 350
Metformin in cancer prevention and therapy.
Kasznicki, J., Śliwińska, A., & Drzewoski, J. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.06.01 · Cited by 316 · cited 1×
“Metformin treatment significantly reduces the sphere-forming ability and inhibits proliferation in the CD44+CD24− and ALDH+ stem-cell-rich population in breast cancer cells [21,24].”
BackgroundMetformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
Song, C. W., Lee, H., Dings, R. P. M., Williams, B., Powers, J., Santos, T. D., Choi, B.-H., & Park, H. J. (2012) · Scientific Reports · doi:10.1038/srep00362 · Cited by 280
Queiroz, E. A. I. F., Puukila, S., Eichler, R., Sampaio, S. C., Forsyth, H. L., Lees, S. J., Barbosa, A. M., Dekker, R. F. H., Fortes, Z. B., & Khaper, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098207 · Cited by 278
The chemistry and biology of vanadium compounds in cancer therapeutics
Kioseoglou, E., Petanidis, S., Gabriel, C., & Salifoglou, A. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.03.010 · Cited by 272
Zhang, Z.-Y. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204161 · Cited by 260
Wang, Y., Xu, W., Yan, Z., Zhao, W., Mi, J., Li, J., & Yan, H. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0731-5 · Cited by 254 · cited 1×
“Activated AMPK suppresses mTOR by phosphorylating and activating the tuberous sclerosis complex (TSC) that negatively regulates mTOR signalling [23,89,90].”
BackgroundZhuang, Y., & Miskimins, W. K. (2008) · Journal of Molecular Signaling · doi:10.1186/1750-2187-3-18 · Cited by 246 · cited 1×
“For instance, AMPK activation is a requirement for cyclin D1 downregulation [61,62].”
BackgroundGuo, D., Hildebrandt, I. J., Prins, R. M., Soto, H., Mazzotta, M. M., Dang, J., Czernin, J., Shyy, J. Y.-J., Watson, A. D., Phelps, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906606106 · Cited by 232 · cited 1×
“Epigallocatechin gallate and analogues MDA-MB-231 (CSCs) * Hep G2 and Hep 3B HCT116 and HT-29 Cell cycle arrest and downregulation of mTOR Downregulation of mTOR and lipogenesis Inhibition of lipogenesis and energy metabolism [75,78,84]”
BackgroundZheng, L., Yang, W., Wu, F., Wang, C., Yu, L., Tang, L., Qiu, B., Li, Y., Guo, L., Wu, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0203 · Cited by 221
Protein-Tyrosine Phosphatase 1B Is Required for HER2/Neu–Induced Breast Cancer
Bentires-Alj, M., & Neel, B. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4610 · Cited by 216
Breast cancer stem cells: Biology and therapeutic implications
Butti, R., Gunasekaran, V. P., Kumar, T. V. S., Banerjee, P., & Kundu, G. C. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.12.001 · Cited by 210 · cited 1×
“In many cases, the relapsed tumour metastasizes, and currently remains incurable [4].”
BackgroundA novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
Zadra, G., Photopoulos, C., Tyekucheva, S., Heidari, P., Weng, Q. P., Fedele, G., Liu, H., Scaglia, N., Priolo, C., Sicinska, E., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201302734 · Cited by 204
Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies
Zadra, G., Batista, J. L., & Loda, M. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0068 · Cited by 194 · cited 1×
“Prolonged AMPK activation also results in mitotic spindle misorientation as well as abnormal chromosome segregation [50].”
BackgroundAMPK‐mediated autophagy inhibits apoptosis in cisplatin‐treated tumour cells
Harhaji‐Trajkovic, L., Vilimanovich, U., Kravic‐Stevovic, T., Bumbasirevic, V., & Trajkovic, V. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00663.x · Cited by 189
Breast cancer stem cells: Features, key drivers and treatment options
Dittmer, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.007 · Cited by 188
Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells
Saini, N., & Yang, X. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx106 · Cited by 174 · cited 3×
“The therapeutic actions of metformin are known to proceed via the induction of cellular stress by the inhibition of oxidative phosphorylation in mitochondria, followed by the activation of AMPK [29].”
BackgroundWiener, J. R., Kerns, B.-J. M., Harvey, E. L., Conaway, M. R., lglehart, J. D., Berchuck, A., & Bast, R. C. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.372 · Cited by 172
Chou, C.-C., Lee, K.-H., Lai, I.-L., Wang, D., Mo, X., Kulp, S. K., Shapiro, C. L., & Chen, C.-S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0135 · Cited by 170 · cited 1×
“EMT in cancer cells is known to generate and maintain stem-like properties in cancer cells and lead to chemoresistance and metastasis [51].”
BackgroundCorrection to: ‘The Warburg Effect: How Does it Benefit Cancer Cells?’
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.01.004 · Cited by 167 · cited 1×
“The greater energy demands are met by the Warburg effect—cancer cells that operate at higher rates of glucose uptake and lactate production irrespective of the available oxygen concentration and normal mitochondrial function [93].”
BackgroundBreast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications
Zeng, X., Liu, C., Yao, J., Wan, H., Wan, G., Li, Y., & Chen, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105320 · Cited by 164
Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
Palomeras, S., Ruiz-Martínez, S., & Puig, T. (2018) · Molecules · doi:10.3390/molecules23092193 · Cited by 163 · cited 1×
“These pathways are often dysregulated in breast cancer and, thus, various approaches are being designed to target them for effective treatment [11].”
BackgroundTargeting the AMP-Activated Protein Kinase for Cancer Prevention and Therapy
Kim, I., & He, Y.-Y. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00175 · Cited by 159
Crans, D. C. (2015) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b02229 · Cited by 151
Wang, S.-T., Ho, H. J., Lin, J.-T., Shieh, J.-J., & Wu, C.-Y. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.472 · Cited by 151
Aryal, P., Kim, K., Park, P., Ham, S., Cho, J. H., & Song, K. (2014) · FEBS Journal · doi:10.1111/febs.12969 · Cited by 145 · cited 1×
“Although the role of autophagy in cancer can be dual and conflicting, there are shreds of evidence suggesting AMPK activation-mediated autophagy results in decreased cell proliferation and cell death [67,68].”
BackgroundLeblanc, C., Vilter, H., Fournier, J.-B., Delage, L., Potin, P., Rebuffet, E., Michel, G., Solari, P. L., Feiters, M. C., & Czjzek, M. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.02.013 · Cited by 145
Signaling pathways governing breast cancer stem cells behavior
Song, K., & Farzaneh, M. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02321-w · Cited by 143
Targeting PTPs with small molecule inhibitors in cancer treatment
Jiang, Z., & Zhang, Z. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9113-3 · Cited by 140
Huang, C., Tsai, S., Wang, Y., Pan, M., Kao, J., & Way, T. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800592 · Cited by 139
Breast cancer stem cells: An overview
Ponti, D., Zaffaroni, N., Capelli, C., & Daidone, M. G. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.031 · Cited by 139 · cited 1×
“Thus, cancer stem cells, or tumour-initiating cells, function like normal stem cells but in a diseased manner [7].”
BackgroundThe strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?
Vara-Ciruelos, D., Russell, F. M., & Hardie, D. G. (2019) · Open Biology · doi:10.1098/rsob.190099 · Cited by 135
Goto, H., Shimono, Y., Funakoshi, Y., Imamura, Y., Toyoda, M., Kiyota, N., Kono, S., Takao, S., Mukohara, T., & Minami, H. (2018) · Oncogene · doi:10.1038/s41388-018-0477-8 · Cited by 130
Vanadium Compounds as PTP Inhibitors
Irving, E., & Stoker, A. W. (2017) · Molecules · doi:10.3390/molecules22122269 · Cited by 129
PTP1B inhibitors for type 2 diabetes treatment: a patent review (2011 – 2014)
Tamrakar, A. K., Maurya, C. K., & Rai, A. K. (2014) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2014.947268 · Cited by 126
Yousefnia, S., Momenzadeh, S., Forootan, F. S., Ghaedi, K., & Nasr‐Esfahani, M. H. (2018) · Gene · doi:10.1016/j.gene.2018.01.018 · Cited by 126
Floyd, S., Favre, C., Lasorsa, F. M., Leahy, M., Trigiante, G., Stroebel, P., Marx, A., Loughran, G., O'Callaghan, K., Marobbio, C. M. T., et al. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-12-1109 · Cited by 124 · cited 2×
“Metformin RPMI8226 and U266 Induction of autophagy and G0/G1 cell cycle arrest and suppression of mTORC1 and mTORC2 [85]”
BackgroundEssentiality and toxicity of vanadium supplements in health and pathology.
Grużewska, K., Michno, A., Pawełczyk, T., & Bielarczyk, H. (2014) · PubMed · Cited by 121
Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?
Vieira, M. N. N., Lyra e Silva, N. M., Ferreira, S. T., & De Felice, F. G. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00007 · Cited by 121
Ci, X., Zhou, J., Lv, H., Yu, Q., Peng, L., & Hua, S. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.39 · Cited by 121 · cited 1×
“Moreover, AMPK also increases inhibitory phosphorylation of glycogen synthase kinase 3 beta (GSK3β), which contributes to mitochondrial protection against iron-induced oxidant stress [97,98].”
BackgroundLee, K., Hsu, E., Guh, J., Yang, M., Wang, D.-S., Kulp, S. K., Shapiro, C. L., & Chen, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264598 · Cited by 114 · cited 1×
“OSU-53 also constrains EMT in breast and prostate cells by activating Foxo3a, thus influencing the cancer stem cell population as well [52].”
BackgroundDual Mechanisms Regulating AMPK Kinase Action in the Ischemic Heart
Baron, S. J., Li, J., Russell, R. R., Neumann, D., Miller, E. J., Tuerk, R., Wallimann, T., Hurley, R. L., Witters, L. A., & Young, L. H. (2005) · Circulation Research · doi:10.1161/01.res.0000155723.53868.d2 · Cited by 108 · cited 1×
“The generally accepted mechanism for physiological AMPK activation involves phosphorylation of the Thr-172 residue within the catalytic active site of AMPKα subunit mainly by LKB1 (liver kinase B1) and CaMKKβ (Ca2+/calmodulin-dependent protein kinase β) [35,36].”
BackgroundTargeting acidity in cancer and diabetes
Gillies, R. J., Pilot, C., Marunaka, Y., & Fais, S. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.003 · Cited by 108
Chen, D., Pamu, S., Cui, Q., Chan, T. H., & Dou, Q. P. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.002 · Cited by 105 · cited 2×
“Thus, mTOR plays a pivotal role in cancer cells, particularly cancer stem cells [84].”
BackgroundCai, X., Hu, X., Tan, X., Cheng, W., Wang, Q., Chen, X., Guan, Y., Chen, C., & Jing, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133349 · Cited by 101
Dai, M., Al-Odaini, A. A., Fils-Aimé, N., Villatoro, M. A., Guo, J., Arakelian, A., Rabbani, S. A., Ali, S., & Lebrun, J. J. (2013) · Breast Cancer Research · doi:10.1186/bcr3441 · Cited by 100
Li, Y.-H., Luo, J., Mosley, Y.-Y. C., Hedrick, V. E., Paul, L. N., Chang, J., Zhang, G., Wang, Y.-K., Banko, M. R., Brunet, A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.054 · Cited by 99
A Brake Becomes an Accelerator: PTP1B—A New Therapeutic Target for Breast Cancer
Tonks, N. K., & Muthuswamy, S. K. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.022 · Cited by 99
Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway
Xu, Q., Wu, N., Li, X., Guo, C., Li, C., Jiang, B., Wang, H., & Shi, D. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2073-4 · Cited by 98
Essential Metals in Medicine: Therapeutic Use and Toxicity of Metal Ions in the Clinic
(2019) · De Gruyter eBooks · doi:10.1515/9783110527872 · Cited by 95
McFadden, J. W., & Corl, B. A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.017 · Cited by 94 · cited 1×
“Therefore, it can be said that activated AMPK acts as the vital controller of lipogenic pathways; and this has direct consequences on oncogenic signalling [76].”
BackgroundPossible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes
Kawabe, K., Yoshikawa, Y., Adachi, Y., & Sakurai, H. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.11.008 · Cited by 92
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
Cao, W., Li, J., Hao, Q., Vadgama, J. V., & Wu, Y. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1107-2 · Cited by 91
Cheng, H. S., Yip, Y. S., Lim, K. Y., Wahli, W., & Tan, N. S. (2021) · Cancers · doi:10.3390/cancers13092153 · Cited by 90
Bao, B., Azmi, A. S., Ali, S. S., Zaiem, F., & Sarkar, F. H. (2014) · PubMed Central · doi:10.3978/j.issn.2305-5839.2014.06.05 · Cited by 89
Kwan, H., Chan, D. W., Cai, P. C. H., Mak, C. S. L., Yung, M. M. H., Leung, T. H. Y., Wong, O. G., Cheung, A., & Ngan, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053597 · Cited by 89
Fifteen years of dancing with vanadium
Crans, D. C. (2005) · Pure and Applied Chemistry · doi:10.1351/pac200577091497 · Cited by 89
Millar, E. K. A., Dean, J. L., McNeil, C. M., O'Toole, S. A., Henshall, S. M., Tran, T., Lin, J., Quong, A., Comstock, C. E. S., Witkiewicz, A., et al. (2009) · Oncogene · doi:10.1038/onc.2009.13 · Cited by 85
Fu, L., Jin, W., Zhang, J., Zhu, L., Lu, J., Zhen, Y., Zhang, L., Ouyang, L., Liu, B., & Yu, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.006 · Cited by 83
Transcriptional suppression of AMPKα1 promotes breast cancer metastasis upon oncogene activation
Yi, Y., Chen, D., Ao, J., Zhang, W., Yi, J., Ren, X., Fei, J., Li, F., Niu, M., Chen, H., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914786117 · Cited by 81
Zhou, J., Chen, Q., Zou, Y., Chen, H., Qi, L., & Chen, Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00820 · Cited by 80 · cited 1×
“Consequently, BCSCs have emerged as important therapeutic targets especially in overcoming metastasis and drug resistance [6].”
BackgroundA systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus
Smith, D. M., Pickering, R. M., & Lewith, G. T. (2008) · QJM · doi:10.1093/qjmed/hcn003 · Cited by 79
CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis
Li, W., Wong, C. C., Zhang, X., Kang, W., Nakatsu, G., Zhao, Q., Chen, H., Go, M. Y. Y., Chiu, P. W. Y., Wang, X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0402-1 · Cited by 78
Xue, B., Pulinilkunnil, T., Murano, I., Bence, K. K., He, H., Minokoshi, Y., Asakura, K., Lee, A., Haj, F., Furukawa, N., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01914-08 · Cited by 77 · cited 2×
“PTP1B is known to negatively modulate AMPK in peripheral tissues [33,150,151], and PTP1B deficiency is known to cause AMPK activation and autophagy [152].”
BackgroundLü, J., Sun, D., Gao, S., Gao, Y., Ye, J., & Liu, P. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14013fp · Cited by 72 · cited 2×
“Although the role of autophagy in cancer can be dual and conflicting, there are shreds of evidence suggesting AMPK activation-mediated autophagy results in decreased cell proliferation and cell death [67,68].”
BackgroundThe Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies
Augimeri, G., Giordano, C., Gelsomino, L., Plastina, P., Barone, I., Catalano, S., Andò, S., & Bonofiglio, D. (2020) · Cancers · doi:10.3390/cancers12092623 · Cited by 71
New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK
Zadra, G., Priolo, C., Patnaik, A., & Loda, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1955 · Cited by 67
Zhang, K., Yang, X., Zhao, Q., Li, Z., Fu, F., Zhang, H., Zheng, M., & Zhang, S. (2020) · Stem Cells International · doi:10.1155/2020/8892300 · Cited by 67
Adipocyte activation of cancer stem cell signaling in breast cancer
Wolfson, B., Eades, G., & Zhou, Q. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i2.39 · Cited by 64
Yang, Z., Wu, F., He, Y., Zhang, Q., Zhang, Y., Zhou, G., Yang, H., & Zhou, P. (2017) · Food & Function · doi:10.1039/c7fo01489a · Cited by 63
Kawakita, E., Yang, F., Kumagai, A., Takagaki, Y., Kitada, M., Yoshitomi, Y., Ikeda, T., Nakamura, Y., Ishigaki, Y., Kanasaki, K., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0115 · Cited by 62 · cited 1×
“AMPK activation by metformin also involves downregulation of mTOR for the anticancer effect [91,92].”
BackgroundKuban‐Jankowska, A., Kostrzewa, T., Musiał, C., Barone, G., Bosco, G. L., Celso, F. L., & Górska‐Ponikowska, M. (2020) · Antioxidants · doi:10.3390/antiox9121208 · Cited by 62
Vanadium and Melanoma: A Systematic Review
Amante, C. I., Sousa‐Coelho, A. L. D., & Aureliano, M. (2021) · Metals · doi:10.3390/met11050828 · Cited by 62
Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK–LKB1 Signaling Axis
Casimiro, M. C., Di Sante, G., Di Rocco, A., Loro, E., Pupo, C., Pestell, T. G., Bisetto, S., Velasco-Velázquez, M. A., Jiao, X., Li, Z., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0425 · Cited by 61 · cited 2×
“Metformin EC109 and EC9706 Cell cycle arrest in G0/G1 phase [65]”
BackgroundCurcumin and Cinnamaldehyde as PTP1B Inhibitors With Antidiabetic and Anticancer Potential
Kostrzewa, T., Przychodzeń, P., Górska‐Ponikowska, M., & Kuban‐Jankowska, A. (2019) · Anticancer Research · doi:10.21873/anticanres.13171 · Cited by 59
Zhang, Y., Storr, S. J., Johnson, K., Green, A. R., Rakha, E. A., Ellis, I. O., Morgan, D. A. L., & Martin, S. G. (2014) · Oncotarget · doi:10.18632/oncotarget.2683 · Cited by 58 · cited 1×
“Similar results have also been observed in clinical studies, wherein enhanced AMPK expression is associated with relapse-free, longer survival rates in breast cancer patients [53].”
ResultLiu, Z., Ren, L., Liu, C., Xia, T., Zha, X., & Wang, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131207 · Cited by 55
Cytotoxic and PTP1B inhibitory activities from Erythrina abyssinica
Nguyễn, P. H., Le, T. V. T., Thương, P. T., Đào, T. T., Ndinteh, D. T., Mbafor, J. T., Kang, K. W., & Oh, W. K. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.108 · Cited by 53
Zou, Y., Xie, C., Yang, S., & Xiong, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6094 · Cited by 53
Nguyễn, P. H., Sharma, G., Đào, T. T., Uddin, M. N., Kang, K. W., Ndinteh, D. T., Mbafor, J. T., & Oh, W. K. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.08.024 · Cited by 51
Protein tyrosine phosphatases in cell adhesion
Young, K. A., Biggins, L., & Sharpe, H. J. (2021) · Biochemical Journal · doi:10.1042/bcj20200511 · Cited by 50
AMPK as a Potential Anticancer Target - Friend or Foe?
Chuang, H.-C., Chou, C.-C., Kulp, S. K., & Chen, C. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990485 · Cited by 49
Zang, Y., Yu, L.-F., Nan, F., Feng, L., & Li, J. X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806887200 · Cited by 49 · cited 1×
“For instance, AMPK activation is a requirement for cyclin D1 downregulation [61,62].”
BackgroundViollet, B., & Foretz, M. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3 · Cited by 48
AMP-activated protein kinase and energy balance in breast cancer.
Zhao, H., Orhan, Y. C., Zha, X., Esencan, E., Chatterton, R. T., & Bulun, S. E. (2017) · Europe PMC (PubMed Central) · Cited by 48
Oleanane triterpenes as protein tyrosine phosphatase 1B (PTP1B) inhibitors from Camellia japonica
Uddin, M. N., Sharma, G., Yang, J., Choi, H. S., Lim, S., Kang, K. W., & Oh, W. K. (2014) · Phytochemistry · doi:10.1016/j.phytochem.2014.04.002 · Cited by 46
Li, Y., Zeng, Q., Qiu, J., Pang, T., Xian, J., & Zhang, X. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0958-z · Cited by 46
Shi, J., Wang, D., Wang, C., Hu, Y., Liu, A., Zhang, Y., Sun, B., & Song, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4470 · Cited by 43
Szklarzewicz, J., Jurowska, A., Hodorowicz, M. A., Kazek, G., Mordyl, B., Menaszek, E., & Sapa, J. (2020) · Transition Metal Chemistry · doi:10.1007/s11243-020-00437-1 · Cited by 43
Vanadium(IV) complexes inhibit adhesion, migration and colony formation of UMR106 osteosarcoma cells
Molinuevo, M. S., Cortizo, A. M., & Etcheverry, S. B. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0532-6 · Cited by 41
The Molecular Mechanisms and Rational Design of Anti-Diabetic Vanadium Compounds
Niu, X., Xiao, R., Wang, N., Wang, Z., Zhang, Y., Xia, Q. H., & Yang, X. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150827094652 · Cited by 41
Tran, Q. H., Hoang, D. H., Song, M., Choe, W., Kang, I., Kim, S. S., & Ha, J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00675-y · Cited by 41
AMPK-dependent activation of the Cyclin Y/CDK16 complex controls autophagy
Dohmen, M., Krieg, S., Agalaridis, G., Zhu, X., Shehata, S. N., Pfeiffenberger, E., Amelang, J., Bütepage, M., Buerova, E., Pfaff, C. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14812-0 · Cited by 40 · cited 2×
“Furthermore, activated AMPK induces autophagy by phosphorylating S326 of cyclin Y, leading to the formation of the cyclin Y–CDK16 complex and activation of CDK16 [66].”
BackgroundLi, X., Lee, Y. J., Jin, F., Park, Y. N., Deng, Y., Kang, Y., Yang, J., Chang, J., Kim, D. Y., Kim, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06835-3 · Cited by 39
Zhang, S., Sheng, H., Zhang, X., Qi, Q., Chan, C. B., Li, L., Shan, C., & Ye, K. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1452-1 · Cited by 39 · cited 2×
“Baicalein PC-3, DU145, and MDA-MB-231 Inhibition of mTOR and autophagy [63]”
BackgroundMartín-Castillo, B., López‐Bonet, E., Cuyàs, E., Viñas, G., Pernas, S., Dorca, J., & Menéndez, J. A. (2015) · Oncotarget · doi:10.18632/oncotarget.6094 · Cited by 36 · cited 1×
“This treatment approach is also proposed to act against the ALDH1 cancer stem cell population [14,15].”
BackgroundWu, Y., Huang, M., Zhao, P., & Yang, X. (2013) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-013-1007-3 · Cited by 36
Liu, L., Yang, Z., Xu, Y., Li, J., Xu, D., Zhang, L., Sun, J., Xia, S., Zou, F., & Liu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073038 · Cited by 36
Zhao, P., & Yang, X. (2013) · Metallomics · doi:10.1039/c3mt20249f · Cited by 36
Lipoic Acid Decreases the Viability of Breast Cancer Cells and Activity of PTP1B and SHP2
Kuban‐Jankowska, A., Górska‐Ponikowska, M., & Woźniak, M. (2017) · Anticancer Research · doi:10.21873/anticanres.11642 · Cited by 36
Cucurbitacin E Induces Autophagy via Downregulating mTORC1 Signaling and Upregulating AMPK Activity
Zha, Q., Zhang, X., Lin, Q.-R., Xu, L., Zhao, G., Pan, H., Zhou, D., Ouyang, D., Liu, Z., & He, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124355 · Cited by 35
Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury
Ito, Y., Hsu, M.-F., Bettaieb, A., Koike, S., Mello, A., Calvo‐Rubio, M., Villalba, J. M., & Haj, F. G. (2017) · Metabolism · doi:10.1016/j.metabol.2017.07.009 · Cited by 35
PTP1B expression is an independent positive prognostic factor in human breast cancer
Soysal, S. D., Obermann, E. C., Gao, F., Oertli, D., Gillanders, W. E., Viehl, C. T., & Muenst, S. E. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2373-1 · Cited by 34
Inhibition of PTP1B disrupts cell–cell adhesion and induces anoikis in breast epithelial cells
Hilmarsdóttir, B., Briem, E., Halldórsson, S., Kricker, J. A., Ingþórsson, S., Gustafsdottir, S., Mælandsmo, G. M., Magnússon, M. K., & Guðjónsson, Þ. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.177 · Cited by 34
Sante, G. D., Pagé, J., Jiao, X., Nawab, O., Cristofanilli, M., Skordalakes, E., & Pestell, R. G. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1615889 · Cited by 34 · cited 1×
“Cyclin D1 plays a crucial role in tumour progression and metastasis by causing abnormal phosphorylation and inhibiting the tumour suppressor protein, retinoblastoma (pRB) [54].”
BackgroundLiu, X., Lv, Y., Zheng, M., Yin, L., Wang, X., Fu, Y., Yu, B., & Li, J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114403 · Cited by 34 · cited 1×
“AICAR Glioblastoma, in vivo Inhibition of lipogenesis and mTOR [74]”
BackgroundTherapeutic potential of mTOR inhibitors for targeting cancer stem cells
Francipane, M. G., & Lagasse, E. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12844 · Cited by 33 · cited 2×
“Many drugs being used clinically today to treat cancers are PI3K/Akt/mTOR suppressors [86,87].”
BackgroundPetanidis, S., Kioseoglou, E., Domvri, K., Zarogoulidis, P., Carthy, J. M., Anestakis, D., Moustakas, A., & Salifoglou, A. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.02.015 · Cited by 33
Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer
Liao, S., Li, J., Yu, L., & Sun, S. (2017) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1600184 · Cited by 31
Kaur, S. P., Nag, A., Gangenahalli, G. U., & Sharma, K. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00554 · Cited by 31
Wang, Y., Pan, H., chen, D., Guo, D., & Wang, X. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104570 · Cited by 31
Wei, C., Zou, H., Xiao, T., Liu, X., Wang, Q., Cheng, J., Fu, S., Peng, J., Xie, X., & Fu, J. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16945 · Cited by 31
Yang, J. L., Ha, T. K. Q., Lee, B.-W., Kim, J., & Oh, W. K. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.09.031 · Cited by 29
Wei, Z., Chen, G., Hu, T., Mo, X., Hou, X., Cao, K., Wang, L., Pan, Z., Wu, Q., Li, X., et al. (2021) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2021.07.010 · Cited by 29 · cited 1×
“Epigallocatechin gallate and analogues MDA-MB-231 (CSCs) * Hep G2 and Hep 3B HCT116 and HT-29 Cell cycle arrest and downregulation of mTOR Downregulation of mTOR and lipogenesis Inhibition of lipogenesis and energy metabolism [75,78,84]”
BackgroundKostrzewa, T., Wołosewicz, K., Jamrozik, M., Drzeżdżon, J., Siemińska, J., Jacewicz, D., Górska‐Ponikowska, M., Kołaczkowski, M., Łaźny, R., & Kuban‐Jankowska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910368 · Cited by 29
Pinter, K., Jefferson, A., Czibik, G., Watkins, H., & Redwood, C. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19412 · Cited by 28 · cited 1×
“The catalytic α subunit is primarily involved in the activation of the kinase, while the AMPKβ and AMPKγ subunits are mainly regulatory [34].”
BackgroundLü, W., Jiao, Huang, Ye, Shi, H., Xiaodong, C., wang, X., Hu, & Xie (2013) · OncoTargets and Therapy · doi:10.2147/ott.s44177 · Cited by 28
Kuban‐Jankowska, A., SAHU, K. K., Górska‐Ponikowska, M., Tuszyński, J. A., & Woźniak, M. (2017) · Anticancer Research · doi:10.21873/anticanres.11886 · Cited by 28
Hwang, S.-L., & Chang, H. W. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1062-4 · Cited by 27
Zhang, L., Huang, Y., Liu, F., Zhang, F., & Ding, W. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.06.013 · Cited by 27
Yan, G., Dai, M., Zhang, C., Poulet, S., Moamer, A., Wang, N., Boudreault, J., Ali, S., & Lebrun, J. J. (2021) · Oncogenesis · doi:10.1038/s41389-021-00310-5 · Cited by 27 · cited 1×
“Cyclin D1 is a vital modulator of mammary and embryonic stem cells and is known to assist transforming growth factor β (TGF-β) in inducing stem cell renewal in triple-negative breast cancer cells [55,56].”
BackgroundTetsuo, F., Arioka, M., Miura, K., Inoue, T., Igawa, K., Tomooka, K., Takahashi‐Yanaga, F., & Sasaguri, T. (2021) · Oncogene · doi:10.1038/s41388-021-01958-4 · Cited by 27
Is the Hypoglycemic Action of Vanadium Compounds Related to the Suppression of Feeding?
Huang, M., Wu, Y., Wang, N., Wang, Z., Zhao, P., & Yang, X. (2014) · Biological Trace Element Research · doi:10.1007/s12011-013-9882-6 · Cited by 26
Hu, C., Li, G., Mu, Y., Wu, W., Cao, B., Wang, Z., Yu, H., Guan, P., Han, L., Li, L., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00085 · Cited by 26
Lee, J. M., Choi, S. S., Park, M. H., Jang, H., Lee, Y. H., Khim, K. W., Oh, S., Park, J., Ryu, H. W., & Choi, J. H. (2020) · Nutrients · doi:10.3390/nu12030773 · Cited by 25 · cited 1×
“Moreover, AMPK also increases inhibitory phosphorylation of glycogen synthase kinase 3 beta (GSK3β), which contributes to mitochondrial protection against iron-induced oxidant stress [97,98].”
BackgroundPenugurti, V., Khumukcham, S. S., Padala, C., Dwivedi, A., Reddy, K. R. K., Srinivasulu, M., Bhopal, T., & Manavathi, B. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.027 · Cited by 25
Huang, Y., Liu, F., Zhang, F., Liu, P., Xu, T., & Ding, W. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.03.006 · Cited by 24
Luo, J., Hou, Y., Xie, M., Ma, W., Shi, D., & Jiang, B. (2020) · Marine Drugs · doi:10.3390/md18050267 · Cited by 24
PTP1B phosphatase as a novel target of oleuropein activity in MCF-7 breast cancer model
Przychodzeń, P., Kuban‐Jankowska, A., Wyszkowska, R., Barone, G., Bosco, G. L., Celso, F. L., Kamm, A., Daca, A., Kostrzewa, T., & Górska‐Ponikowska, M. (2019) · Toxicology in Vitro · doi:10.1016/j.tiv.2019.104624 · Cited by 23
Chandel, S., Manikandan, A., Mehta, N., Nathan, A. A., Tiwari, R. K., Mohapatra, S. B., Chandran, M., Jaleel, A., Manoj, N., & Dixit, M. (2020) · Journal of Cell Science · doi:10.1242/jcs.250274 · Cited by 23
Drug Repurposing in Oncology: Current Evidence and Future Direction
Zhang, Z., Ji, J., & Liu, H. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999200820124111 · Cited by 22
Protein tyrosine phosphatase PTP1B in cell adhesion and migration
Arregui, C. O., González, Á., Burdisso, J. E., & Wusener, A. E. G. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.26375 · Cited by 21
Tang, J., Wu, W., Yang, F., Liu, L., Yang, Z., Liu, L., Tang, W., Sun, F., & Lin, H. (2018) · Cancer Medicine · doi:10.1002/cam4.1640 · Cited by 21 · cited 1×
“Marine sponge-derived smenospongine MCF7, HBL100, and 16HBE (CSCs) * Cell cycle arrest and downregulation of Nanog, Bmi1, and Sox2 [30]”
BackgroundOxidovanadium(V) complexes as promising anticancer photosensitizers
Noriega, L., Castro, M. E., Perez‐Aguilar, J. M., Caballero, N. A., Sánchez-Gaytán, B. L., Vergara, E. G., & Meléndez, F. J. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110862 · Cited by 21
Johnson, J., Rychahou, P. G., Sviripa, V. M., Weiss, H. L., Liu, C., Watt, D. S., & Evers, B. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209392 · Cited by 20
Beijersbergen, R. L. (2020) · Nature Cancer · doi:10.1038/s43018-020-0024-8 · Cited by 19
Silva‐Nolasco, A. M., Camacho, L., Saavedra-Díaz, R. O., Hernández‐Abreu, O., León, I. E., & Sánchez‐Lombardo, I. (2020) · Inorganics · doi:10.3390/inorganics8120067 · Cited by 19
Turtoi, M., Anghelache, M., Pătraşcu, A., Maxim, C., Mânduțeanu, I., Călin, M., & Popescu, D. (2021) · Biomedicines · doi:10.3390/biomedicines9050562 · Cited by 19
Dronamraju, V., Ibrahim, B. A., Briski, K. P., & Sylvester, P. W. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1599969 · Cited by 18
Docosahexaenoic Acid Inhibits PTP1B Phosphatase and the Viability of MCF-7 Breast Cancer Cells
Kuban‐Jankowska, A., Górska‐Ponikowska, M., Sahu, K. K., Kostrzewa, T., Woźniak, M., & Tuszyński, J. A. (2019) · Nutrients · doi:10.3390/nu11112554 · Cited by 17
Cuong, T. D., Hoang, D.-T., Tran, M. H., Quân, P. M., Huynh, N. T., & Nguyễn, P. H. (2020) · Natural Product Communications · doi:10.1177/1934578x19899517 · Cited by 16
Kim, J. H., Lee, J. O., Kim, N., Lee, H. J., Lee, Y. W., Kim, H. I., Kim, S. J., Park, S. H., & Kim, H. S. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3153 · Cited by 15 · cited 1×
“Paclitaxel, a well-known and commonly used drug for the treatment of breast and lung cancers, involves the activation of AMPK during its therapeutic pathway [48].”
BackgroundProtein tyrosine phosphatase 1B(PTP1B) promotes melanoma cells progression through Src activation
Wang, Q., Pan, Y., Zhao, L., Qi, F., & Liu, J. (2021) · Bioengineered · doi:10.1080/21655979.2021.1988376 · Cited by 15
Ghrelin Affects Gastric Cancer Progression by Activating AMPK Signaling Pathway
Hu, X., Zhu, Y., Hu, C., You, L., Wu, J., He, X., Huang, W., & Wu, Z. (2021) · Biochemical Genetics · doi:10.1007/s10528-020-10022-x · Cited by 14
14. Chemical and Clinical Aspects of Metal-Containing Antidotes for Poisoning by Cyanide
Carver, P. L., Meunier, B., Robert, A., Crisponi, G., Nurchi, V. M., Lachowicz, J. I., Nairz, M., Weiss, G., Pai, A. B., Ward, R. J., et al. (2019) · De Gruyter eBooks · doi:10.1515/9783110527872-020 · Cited by 13
Zhang, S., Yan, L., & Kim, S. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239547 · Cited by 12
Im, C. (2016) · IUBMB Life · doi:10.1002/iub.1475 · Cited by 9
Cai, J., Qiong, G., Li, C., Sun, L., Luo, Y., Yuan, S., Gonzalez, F. J., & Xu, J. (2021) · The FASEB Journal · doi:10.1096/fj.202002126rr · Cited by 9
Li, J., & Min, Y. (2021) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-021-09915-2 · Cited by 9 · cited 2×
“Salinomycin RB 383, WERI-Rb-1 and RB116 (CSCs) * Inhibition of mitochondrial respiration and mTOR [88]”
BackgroundTan, C., Dong, Y., Wang, J., & Yang, X. (2019) · New Journal of Chemistry · doi:10.1039/c9nj00820a · Cited by 8
Liu, Q., Li, L., Gao, L., Li, C., Huan, Y., Lei, L., Cao, H., Li, L., Gao, A., Liu, S., et al. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13573 · Cited by 7
Yun, J.-H., Park, S., Choi, G.-H., Park, I.-J., Lee, J. H., Lee, O., Kim, J.-H., Seo, Y.-H., & Cho, J. (2018) · Food Science and Biotechnology · doi:10.1007/s10068-018-0436-8 · Cited by 6
Dai, M., Al-Odaini, A. A., Fils-Aimé, N., Villatoro, M., Guo, J., Arakelian, A., Rabbani, S. A., Ali, S., & Lebrun, J. J. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0831-8 · Cited by 4 · cited 2×
“Cyclin D1 is a vital modulator of mammary and embryonic stem cells and is known to assist transforming growth factor β (TGF-β) in inducing stem cell renewal in triple-negative breast cancer cells [55,56].”
BackgroundThe effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer
Waissengrin, B., Zahavi, T., Salmon‐Divon, M., Goldberg, A., Wolf, I., Rubinek, T., Winkler, T., Farkash, O., Grinshpun, A., Zubkov, A., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100648 · Cited by 4
Beyene, Z. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.47191/ijpbms/v1-i7-02 · Cited by 2
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Waissengrin, B., Wolf, I., Zahavi, T., Salmon‐Divon, M., & Sonnenblick, A. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.15_suppl.e12505 · Cited by 1
Cited by
Meta-hallmarks of aging and cancer
López-Otín, C., Pietrocola, F., Roiz-Valle, D., Galluzzi, L., & Kroemer, G. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.11.001 · Cited by 529
The role of AMPK in macrophage metabolism, function and polarisation
Cui, Y., Chen, J., Zhang, Z., Shi, H., Sun, W., & Yi, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04772-6 · Cited by 185
Targeting Breast Cancer: An Overlook on Current Strategies
Iacopetta, D., Ceramella, J., Baldino, N., Sinicropi, M., & Catalano, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043643 · Cited by 88
Wang, J., Shao, F., Yu, Q., Ye, L., Wusiman, D., Wu, R., Tuo, Z., Wang, Z., Li, D., Cho, W. C. S., et al. (2025) · Research · doi:10.34133/research.0612 · Cited by 72
“Upon activation, AMPK triggers several pathways to restore energy balance, such as promoting glucose uptake and fatty acid oxidation while inhibiting energy-consuming processes like protein synthesis [ 2 , 292 ].”
Repurposing Therapeutic Drugs Complexed to Vanadium in Cancer
Sousa‐Coelho, A. L. D., Fraqueza, G., & Aureliano, M. (2023) · Pharmaceuticals · doi:10.3390/ph17010012 · Cited by 39
“Involved pathways for vanadium compounds may include AMP-activated protein kinase (AMPK) activation and protein tyrosine phosphatase 1B (PTP1B) inhibition pathways, as described for the treatment of breast cancer [26].”
Background
Metadata
- Authors
- Uprety, B., & Abrahamse, H.
- Affiliations
- University of Johannesburg (ZA)
- Corresponding author
- Uprety, Bhawna
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-02-07
- Volume
- 11
- Issue
- 3
- Pages
- 576
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC8834477
- OpenAlex
- W4210907560
- Cited by
- 33
- References
- 189
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 6 · 2023: 9 · 2022: 5
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation of South Africa (98337)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Physical Sciences › Chemistry › Inorganic Chemistry › Vanadium and Halogenation Chemistry
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- breast cancer, cancer stem cells, AMPK activation, metformin, vanadium compounds, PTP1B inhibition, insulin mimetics, anticancer drug targets, stem cell-like properties
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplastic Stem Cells, Vanadium Compounds, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.